Lantheus Holdings (LNTH) Reiterated at Market Outperform by Citizens on FDA CRL

June 29, 2026 4:23 AM

Citizens analyst David Turkaly reiterated a Market Outperform rating and $115.00 price target on Lantheus Holdings (NASDAQ: LNTH).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found